top of page
TANA THERAPEUTICS
Tissue Engineering Re-Imagined
OUR TECHNOLOGY
Tana-Porter™ is a state-of-the-art cell penetration peptide
that fully exploits the endocytic pathway achieving:
>90% efficacy in late endosomal release of "cargos"
>95% cell viability post exposure.
Tana-Porter™ is broken down and digested by cells once released in the cytoplasm.
OUR RESEARCH
Conducted by our founders at Texas A&M University.
bottom of page